For following the competition: what moved in each program, several studies read as one move.
- ivonescimab
- cadonilimab
- ligufalimab
- + 14 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Akeso to watchlistEvery Monday by email · turn it off any timePro · free during the beta